Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jul;40(1):95–97. doi: 10.1111/j.1365-2125.1995.tb04543.x

Influence of arterio-venous haemofiltration on teicoplanin elimination.

D Hillaire-Buys 1, H Peyriere 1, E Lobjoie 1, J Bres 1, M Ossart 1, E Despaux 1
PMCID: PMC1365036  PMID: 8527277

Abstract

The pharmacokinetics of teicoplanin infused for 30 min at a dose of 6 mg kg-1 was studied in 11 infected patients under continuous arterio-venous haemofiltration (CAVH). Serum teicoplanin levels were assayed by h.p.l.c. over 24 h. After 0.5 h, i.e. at the end of the infusion, the mean plasma concentration was 49.6 +/- 15.1 mg l-1. At the last sampling time (24 h), the mean concentration was 2.6 +/- 1.0 mg l-1. The concentration of teicoplanin was determined in the haemofiltrates. The percentage of the administered dose recovered in the haemofiltrate was low: less than 1% for seven patients, between 1.8 and 3.7% for three patients and 7% for one patient. CAVH patients should be given teicoplanin using the same dosage regimens as previously described for patients with renal impairment.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonati M., Traina G. L., Villa G., Salvadeo A., Gentile M. G., Fellin G., Rosina R., Cavenaghi L., Buniva G. Teicoplanin pharmacokinetics in patients with chronic renal failure. Clin Pharmacokinet. 1987 Apr;12(4):292–301. doi: 10.2165/00003088-198712040-00003. [DOI] [PubMed] [Google Scholar]
  2. Garraffo R., Iliadis A., Cano J. P., Dellamonica P., Lapalus P. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J Pharm Sci. 1989 Sep;78(9):753–757. doi: 10.1002/jps.2600780911. [DOI] [PubMed] [Google Scholar]
  3. Kramer P., Kaufhold G., Gröne H. J., Wigger W., Rieger J., Matthaei D., Stokke T., Burchardi H., Scheler F. Management of anuric intensive-care patients with arteriovenous hemofiltration. Int J Artif Organs. 1980 Jul;3(4):225–230. [PubMed] [Google Scholar]
  4. Levy J., Truong B. L., Goignau H., Van Laethem Y., Butzler J. P., Bourdoux P. High pressure liquid chromatographic quantitation of teicoplanin in human serum. J Antimicrob Chemother. 1987 Apr;19(4):533–539. doi: 10.1093/jac/19.4.533. [DOI] [PubMed] [Google Scholar]
  5. Rowland M. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet. 1990 Mar;18(3):184–209. doi: 10.2165/00003088-199018030-00002. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES